Influence of blood coagulation factor XIII and FXIII Val34Leu on plasma clot formation measured by thrombelastography

Thrombosis Research

Volumn 104, Issue 6, 2001, Pages 467-474

  Schroeder, Verena ^a   Chatterjee, Tushar ^b   Kohler, Hans Peter ^a  

^a UNIVERSITY OF BERN   (Switzerland)

^b BERN UNIVERSITY HOSPITAL   (Switzerland)

Author keywords

Coagulation factor XIII; Factor XIII Val34Leu polymorphism; Thrombelastography

Indexed keywords

BLOOD CLOTTING FACTOR; BLOOD CLOTTING FACTOR 13; BLOOD CLOTTING FACTOR 13[34 LEUCINE]; CITRIC ACID; LEUCINE; UNCLASSIFIED DRUG; VALINE;

ALLELE; ANALYTICAL PARAMETERS; ARTICLE; BLOOD CLOTTING; BLOOD CLOTTING TIME; BLOOD SAMPLING; COMPARATIVE STUDY; CONTROLLED STUDY; GENETIC POLYMORPHISM; GENOTYPE; HOMOZYGOTE; HUMAN; NORMAL HUMAN; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN BLOOD LEVEL; PROTEIN POLYMORPHISM; SENSITIVITY AND SPECIFICITY; STATISTICAL ANALYSIS; THROMBOELASTOGRAPHY;

AMINO ACID SUBSTITUTION; BLOOD COAGULATION; BLOOD COAGULATION TESTS; FACTOR XIII; FACTOR XIII DEFICIENCY; GENOTYPE; HUMANS; PLASMA; POLYMORPHISM, GENETIC; SENSITIVITY AND SPECIFICITY; THROMBELASTOGRAPHY;

EID: 0035894634     PISSN: 00493848     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0049-3848(01)00395-4     Document Type: Article

References (34)

1. The physiology and biochemistry of factor XIII
2. 2-plasmin inhibitor to fibrin by fibrin-stabilizing factor
3. Human procarboxypeptidase U, or thrombin-activatable fibrinolysis inhibitor, is a substrate for transglutaminases
4. Association of a common polymorphism in the factor XIII gene with myocardial infarction
5. Association of FXIII Val34Leu with decreased risk of myocardial infarction in Finnish males
6. The association between the Val34Leu polymorphism in the factor XIII gene and brain infarction
7. Prevalence of three common polymorphisms in the A-subunit gene of factor XIII in patients with coronary artery disease
8. Association of a common polymorphism in the factor XIII gene with venous thrombosis
9. Role of factor XIII Val34Leu in cardiovascular disease
10. Mechanisms of disease: Plasminogen-activator inhibitor type 1 and coronary artery disease
11. The FXIII Val 34 Leu mutation and the risk of venous thrombosis
12. Examining thrombin hydrolysis of the factor XIII activation peptide segment leads to a proposal for explaining the cardioprotective effects observed with the factor XIII V34L mutation
13. The factor XIII V34L polymorphism accelerates thrombin activation of factor XIII and affects cross-linked fibrin structure
14. Blutgerinnungsstudien mit der thrombelastographie, einem neuen untersuchungsverfahren
15. Thrombelastography
16. The thromboelastograph and the thromboelastograph technique
17. The normal thromboelastogram and its interpretation
18. Perspectives on thromboelastography
19. Studies on the evaluation of factor XIII (fibrin-stabilizing factor) by means of the MIA tolerance (visual and thrombelastographic technique)
20. Congenital hemorrhagic diathesis with deficiency of factor XIII. A case report and a family study
21. The detection and measurement of factor XIII activity: A review
22. Factor XIII in human plasma and platelets
23. Fibrin crosslinking demonstrated by thrombelastography
24. Erhöhung der gerinnselfestigkeit vor und nach herzchirurgischen eingriffen durch zusatz von faktor XIII in vitro
25. The Val34Leu polymorphism in the A subunit of coagulation factor XIII contributes to the large normal range in activity and demonstrates that the activation peptide plays a role in catalytic activity
26. Subunit antigen and activity levels of blood coagulation factor XIII in healthy individuals. Relation to sex, age, smoking and hypertension
27. Gerinnungsphysiologische schnell-methode zur bestimmung des fibrinogens
28. A common coding polymorphism in the factor XIII A-subunit gene (FXIIIVal34Leu) affects cross-linking activity
29. 2-antiplasmin incorporation into fibrin
30. Effect of the FXIII Val34Leu polymorphism on the interaction between platelets and cross-linked fibrin
31. Fibrinogen, factor VII and PAI-1 genotypes and the risk of coronary and peripheral atherosclerosis: Edinburgh Artery Study
32. Polymorphisms in the factor VII gene and the risk of myocardial infarction in patients with coronary artery disease
33. Role of hemostatic gene polymorphisms in venous and arterial thrombotic disease